Change Text Size
| Register
Search video content
Filter results by:
1.4k Views
Not yet rated
0

Promising breakthroughs for immunotherapy for cancer treatment

Prof Paul Sondel explains the advances in cancer detection, diagnosis and survival.

1.1k Views
Not yet rated
0

Ibrutinib is a new and effective treatment for relapsed chronic lymphocytic leukaemia

Dr John Byrd discusses a new treatment involving Ibrutinib which has been FDA and EC approved in 2014 for the treatment of relapsed chronic lymphocytic leukaemia.

1k Views
Not yet rated
0

A new treatment for relapsed chronic lymphocytic leukaemia (CLL)

Dr Jennifer Brown discusses the drug Idelalisib and it's role in improving survival with patients suffering from relapsed Chronic Lymphocytic Leukaemia (CLL).

2.4k Views
Not yet rated
0

How can patients contribute to the improvement of cancer care?

Lt. Col. David Hamilton discusses his involvement in cancer care and the benefits of partaking in clinical trials.

4.4k Views
Not yet rated
0

Should I take part in a clinical trial?

Richard Stephens of NCRI and NCRN Consumer Liaison Groups, UK discusses clinical trials and the factors patients should consider before taking part.

2.8k Views
Not yet rated
0

Patient involvement in clinical trials

Shirley Harrison discusses her involvement with patient liaison groups and clinical trials.